Medeze Group PCL (MEDEZE)

Currency in THB
6.45
0.00(0.00%)
Closed·
Advertisement
MEDEZE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.456.55
52 wk Range
6.007.80
Key Statistics
Bid/Ask
6.45 / 6.55
Prev. Close
6.45
Open
6.5
Day's Range
6.45-6.55
52 wk Range
6-7.8
Volume
246.3K
Average Volume (3m)
566.98K
1-Year Change
-10.4167%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDEZE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.90
Upside
+22.48%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.90
(+22.48% Upside)

Earnings

Latest Release
12/05/2026
EPS / Forecast
0.03 / --
Revenue / Forecast
175.61M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.15%
Dividend Yield
2.48%
Industry Median 4.58%
Annualised payout
0.16
Paid unevenly
5-Years Growth
-
Growth Streak

Compare MEDEZE to Peers and Sector

Metrics to compare
MEDEZE
Peers
Sector
Relationship
P/E Ratio
44.1x18.4x−0.3x
PEG Ratio
−0.720.060.00
Price/Book
2.3x1.3x2.6x
Price / LTM Sales
9.4x1.7x3.0x
Upside (Analyst Target)
22.5%14.1%56.3%
Fair Value Upside
Unlock26.7%9.2%Unlock

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in research, develops, and collects data on all types of human cellular activities and medical laboratory tests. Further, the company sells dietary supplements, cosmetics, and dermo cosmetics. Medeze Group Public Company Limited was founded in 2010 and is based in Nakhon Pathom, Thailand.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
370.45M34.69%2.39B
Public Companies & Retail Investors
697.55M65.31%4.50B
Total
1.07B100.00%6.89B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Medeze Holding Co., Ltd33.77%360,700,2572,326,517
Karmarts Public Company Limited0.91%9,750,00062,888

People Also Watch

5.70
MCOT
+0.88%
2.94
MATI
+1.38%
17.60
MTI
+1.15%

FAQ

What Is the Medeze PCL (Thailand: MEDEZE) Share Price Today?

The Medeze PCL stock price today is 6.45 THB.

What Stock Exchange Does Medeze PCL (MEDEZE) Trade On?

Medeze PCL is listed and trades on the Thailand Stock Exchange.

What Is the Ticker (Stock Symbol) for Medeze PCL?

The stock symbol (also called a 'ticker') for Medeze PCL is "MEDEZE."

Does Medeze PCL Pay Dividends? What’s The Current MEDEZE Dividend Yield?

Yes, MEDEZE Pays Dividends to its Shareholders. The current Medeze PCL dividend yield is 2.48%.

What Is the Current Medeze PCL Market Capitalisation?

As of today, Medeze PCL (Thailand: MEDEZE) market cap is 6.89B THB.

What Is Medeze PCL's (MEDEZE) Earnings Per Share (TTM)?

The Medeze PCL EPS is currently 0.15 (Trailing Twelve Months).

When Is the Next Medeze PCL Earnings Date?

Medeze PCL's next earnings report will be released on 19/08/2026.

Is MEDEZE a Buy or Sell From a Technical Analyst Perspective?

Based on today's Medeze PCL moving averages and other technical indicators, the daily buy/sell signal for MEDEZE stock is Sell.

How Many Times Has Medeze PCL Stock Split?

Medeze PCL has split 0 times. (See the MEDEZE stock split history page for full effective split date and price information.)

How Many Employees Does Medeze PCL Have?

Medeze PCL has 200 employees, based on their latest Companies House report.

What is the current trading status of Medeze PCL (Thailand: MEDEZE)?

As of 02/08/2026, Medeze PCL (MEDEZE) is trading at a share price of 6.45 THB, with a previous close of 6.45 THB. The stock has fluctuated within a day range of 6.45 THB to 6.55 THB, while its 52-week range spans from 6.00 THB to 7.80 THB.

What Is Medeze PCL (MEDEZE) Price Target According to Analysts?

The average 12-month price target for Medeze PCL is 7.90 THB, with a high estimate of 7.9 THB and a low estimate of 7.9 THB. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +22.48% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.